AtriCure Inc. (NASDAQ:ATRC) reported its Q4 2024 earnings, revealing a wider-than-expected loss per share but exceeding revenue forecasts. The company's stock fell in aftermarket trading following the ...
By now, many have seen the commercials with NBA legend Kareem Abdul-Jabbar explaining the importance of seeing ...
Doctors at Queen Mary University of London, Barts Health NHS Trust, and University College London have led the development of ...
NeuroOne Medical Technologies Corporation ( NASDAQ: NMTC) Q1 2025 Earnings Conference Call February 12, 2025 8:30 AM ET ...
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q1 2025Management ViewCEO Dave Rosa highlighted the strong performance ...
Total revenue of $6.3M Includes $3.3 Million of Product Revenue in Addition to a One-Time Upfront Payment of $3.0 Million in License Revenu ...
Reports Q1 product revenue $3.3M vs. $1M last year. Reports Q1 license revenue $3M vs. $0 last year. “This quarter marks the next step forward ...
Triple T offers a faster, safer alternative to surgery, by selectively destroying the small adrenal nodule without removing the adrenal gland.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback